News Feature Channel: Personalized Medicine

$75 Million Donation From AbbVie Foundation to Support UChicago Medicine's New Cancer Pavilion

University of Chicago Medical Center — Thu, 31 Oct 2024 08:25:32 EST

The AbbVie Foundation, a nonprofit working to advance health equity, is donating $75 million to UChicago Medicine to support the $815 million cost to construct a state-of-the-art cancer care pavilion, the first and only freestanding facility of its kind in Illinois.

Danforth Technology Company Launches New Startup

Donald Danforth Plant Science Center — Mon, 28 Oct 2024 09:30:14 EST

The Danforth Technology Company (DTC) today announced the launch of Metablify, a startup that has developed a breakthrough technology platform that enables the detection and quantification of previously undetectable metabolites and chemicals in large numbers of biological samples processed using LC/MS data processing algorithms.

Fine-Tuning the Tools That Enhance Reproducibility

SLAS — Thu, 17 Oct 2024 12:10:40 EST

Fine-tuning the Tools that Enhance Reproducibility

Researchers Help Redefine Core Microbiome, Opening New Chapter in Precision Health

Rutgers University-New Brunswick — Wed, 16 Oct 2024 12:25:33 EST

Researchers at Rutgers University-New Brunswick, along with international collaborators, have introduced a novel method for identifying the crucial set of gut microbes commonly found in humans and essential for health.

Nipple-Sparing Mastectomy: A Modern Approach to Breast Cancer Surgery

Rutgers Cancer Institute — Fri, 11 Oct 2024 13:05:39 EST

Nipple-Sparing Mastectomy (NSM) is a surgical option for patients requiring a mastectomy, in which the breast tissue is removed while the skin, nipple, and areola remain intact. This procedure allows for immediate reconstruction and offers a more natural post-surgery result, giving patients both peace of mind and a sense of body confidence. M. Michele Blackwood, MD, FACS, director of Breast Surgery and director of Women's Oncologic Health, RWJBarnabas Health and Rutgers Cancer Institute shares more on this surgical technique.

UNC Fast-Tracks Personalized Treatment for Twins with Ultra Rare Genetic Disorder

University of North Carolina School of Medicine — Thu, 26 Sep 2024 11:05:59 EST

At 7-years-old, Amelia and Makenzie Kahn were diagnosed with juvenile Batten disease, an extremely rare and progressively fatal genetic disorder. Instead of giving in to the disease, the Kahn family searched for a treatment.

Organoids Derived From Gut Stem Cells Reveal Two Distinct Molecular Subtypes of Crohn's Disease

University of California San Diego — Thu, 26 Sep 2024 11:00:00 EST

UC San Diego researchers discover two distinct molecular subtypes of Crohn's disease using patient-derived organoids, opening the door to personalized treatment for the chronic inflammatory bowel disease.

ESMO: Combination Therapy Reduced Agitated Delirium in Patients with Advanced Cancers

University of Texas MD Anderson Cancer Center — Sat, 14 Sep 2024 09:45:00 EST

Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, compared with haloperidol alone, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center.

Global Experts Converge at CICON24 to Unveil Groundbreaking Advances in Cancer Immunotherapy, September 8-11, 2024 at National Harbor, MD

Cancer Research Institute — Fri, 06 Sep 2024 12:20:45 EST

CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.

ARPA-H project to pioneer rapid manufacturing of tumor models

University Of Illinois Grainger College Of Engineering — Tue, 20 Aug 2024 13:05:18 EST

Advanced imaging and AI will power the manufacture of any cancer at the push of a button.

Targeting cancer with precision: neoantigen vaccines show promise

Chinese Academy of Sciences — Mon, 19 Aug 2024 07:05:24 EST

In an elegant fusion of science and medicine, neoantigen cancer vaccines are emerging as a formidable strategy in the battle against cancer. These vaccines, a testament to the power of personalized medicine, target cancer's unique protein signatures, rallying the immune system for a precise and potent attack.

Decoding calcifications in breast cancer: towards personalized medicine

Chinese Academy of Sciences — Tue, 13 Aug 2024 10:05:11 EST

A pivotal study uncovers the molecular signatures of mammographic calcifications in hormone receptor-positive, HER2-negative breast cancer.

Advancing the battle against Hodgkin's lymphoma: new treatment insights

Chinese Academy of Sciences — Tue, 13 Aug 2024 08:05:00 EST

In a notable advancement for Hodgkin's lymphoma (HL), recent research has introduced sophisticated therapeutic strategies designed to significantly boost patient outcomes.

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

St. Jude Children's Research Hospital — Mon, 05 Aug 2024 17:05:57 EST

Explore how scientists at St. Jude Children's Research Hospital have identified causes for age-related differences in treatment outcomes of B-cell acute lymphoblastic leukemia.

The consequences of ending abortion protection, the patient perspective on laboratory developed tests, health equity, and more to be explored at ADLM 2024

Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC)) — Sun, 28 Jul 2024 18:00:00 EST

At ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) in Chicago, more than 300 experts will present cutting-edge research and technology that will shape the future of laboratory medicine and improve patient care.

Study Identifies Biomarker that Could Predict Whether Colon Cancer Patients Benefit from Chemotherapy

Sylvester Comprehensive Cancer Center — Fri, 26 Jul 2024 16:05:45 EST

A new study identifies and validates a 10-gene biomarker that potentially predicts whether a stage II or III colon cancer patient will benefit from adjuvant chemotherapy. A secondary finding from the study suggests that the gene signature could potentially also predict whether immunotherapy would help some patients.

Antidepressants May Increase Risk of Relapse in People with Alcohol Use Disorder

Research Society on Alcoholism — Fri, 26 Jul 2024 10:00:00 EST

Antidepressants may reduce the risk of relapse in people with alcohol use disorder--but only if the antidepressants are effective in reducing their depression symptoms. People whose depression symptoms do not improve with antidepressant treatment may have an increased risk for relapse into problem alcohol use.

FAU Researcher Receives Grant to Personalize Radiation Therapy for Cancer

Florida Atlantic University — Thu, 25 Jul 2024 08:30:51 EST

While chemotherapy has advanced in personalization, personalized radiation therapy for cancer remains underdeveloped. A new project will use AI, in particular, deep reinforcement learning, to analyze multimodal data, and enhance cancer characterization and treatment to ultimately improve patient outcomes. Using personal health data, genetic information about the tumor, and patient treatment and follow-up data, digital twins will simulate diagnoses and treatment options to help physicians choose the most effective treatments and monitor responses over time.

BePRECISE consortium unveils guidelines to enhance reporting in precision medicine research

University of the Witwatersrand, Johannesburg — Wed, 24 Jul 2024 06:05:21 EST

The inaugural reporting guidelines for precision medicine research, of which Wits University Professor Michele Ramsay is co-author, have been published in Nature Medicine.

Drug delivery via textile fibers

Empa, Swiss Federal Laboratories for Materials Science and Technology — Tue, 25 Jun 2024 03:05:47 EST

Medical products such as ointments or syringes reach their limits when it comes to delivering medication locally - and above all in a controlled manner over a longer period of time. Empa researchers are therefore developing polymer fibers that can deliver active ingredients precisely over the long term. These "liquid core fibers" contain drugs inside and can be processed into medical textiles.